T CELL MEMORY Efficient at Migrating to Inflamed Peripheral Tissues

Total Page:16

File Type:pdf, Size:1020Kb

T CELL MEMORY Efficient at Migrating to Inflamed Peripheral Tissues RESEARCH HIGHLIGHTS T CELL MEMORY efficient at migrating to inflamed peripheral tissues. These data suggest that tissue-resident memory CD8+ T cells markedly outnumber those New insight on old-timers that are recirculating and that our current paradigms of memory T cell Memory T cells ensure that the recirculate between the blood and subsets require revision. immune response is more effective non-lymphoid tissues and respond Cui et al. explored how metabolic against re-infecting pathogens. Two rapidly to re-infecting pathogens. processes regulate longevity in mem- key distinctions between memory A further set of tissue-resident mem- ory CD8+ T cells. They compared + CD8 T cells and their naive counter- ory T (TRM) cells have been described gene expression profiles of naive, parts are crucial for this: first, mem- that are retained in non-lymphoid effector and memory CD8+ T cells ory T cells have distinct migratory tissues and do not recirculate. The and found that the glycerol channel patterns; and second, they survive for relative contribution of each subset to aquaporin 9 (AQP9) was selectively longer. New studies by Steinert et al. immune memory has been unclear; expressed by memory CD8+ T cells. and Cui et al. offer fresh insight into to address this, Steinert et al. devel- These cells were shown to upregulate both of these aspects of memory. oped a quantitative immunofluores- AQP9 in response to stimulation Memory CD8+ T cells have been cence microscopy (QIM) method. with interleukin‑7 (IL‑7) — and, to a divided into distinct subsets on the our current In a mouse model of lymphocytic lesser extent, in response to IL‑15 — basis of putative trafficking and func- paradigms choriomeningitis virus (LCMV) and deficiency of AQP9 impaired the tional properties. Central memory T infection, standard protocols for cell survival of memory but not effector of memory + (TCM) cells are suggested to be long- isolation markedly underestimated CD8 T cells during LCMV infection. lived memory cells that recirculate T cell subsets the frequencies of LCMV-specific Further experiments suggested via secondary lymphoid organs require revision memory CD8+ T cells in tissues, that AQP9 deficiency impairs (SLOs), whereas effector memory T particularly in non-lymphoid sites, memory CD8+ T cell survival by (TEM) cells are thought to primarily when compared with QIM. Indeed, preventing glycerol uptake, which QIM analyses suggested that more is required for the synthesis of memory CD8+ T cells are found in tri­glycerides. Triglycerides serve the blood and peripheral tissues as a source of fatty acids for fatty than in SLOs. acid oxidation, a metabolic process Parabiosis experiments showed that generates energy for memory that most memory CD8+ T cells in T cell survival. Consistent with this, peripheral tissues do not recirculate. AQP9‑deficient memory CD8+ T cells This suggests that the majority had reduced ATP levels, and the of memory CD8+ T cells in non- overexpression of genes involved in lymphoid tissues are TRM cells, rather triglyceride synthesis prolonged their than TEM cells, although bona fide survival. Additional analyses showed TEM cells could be detected exiting that IL‑7 also increases the expression tissues via lymphatics. CD69 expres- of genes involved in triglyceride sion is often used to define TRM cells, synthesis in previously activated but but the authors found that a sub- not naive CD8+ T cells. Therefore, stantial number of resident memory IL‑7 promotes memory CD8+ T cell CD8+ T cells do not express this survival not only through the induc- marker. Furthermore, many of the tion of anti-apoptotic genes but memory CD8+ T cells that entered also by supporting their metabolic peripheral tissues (a migratory activities. behaviour associated with TRM cells Yvonne Bordon or TEM cells) expressed the lymph ORIGINAL RESEARCH PAPERS Steinert, E. M. et al. node-homing molecule CD62L, Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell which is typically used to define 161, 737–749 (2015) | Cui, G. et al. IL‑7‑induced TCM cells. In fact, adoptive transfer glycerol transport and TAG synthesis promotes experiments showed that purified memory CD8+ T cell longevity. Cell 161, 750–761 Creative Images/Alamy Creative (2015) TCM cells and TEM cells were equally NATURE REVIEWS | IMMUNOLOGY VOLUME 15 | JUNE 2015 © 2015 Macmillan Publishers Limited. All rights reserved.
Recommended publications
  • Our Immune System (Children's Book)
    OurOur ImmuneImmune SystemSystem A story for children with primary immunodeficiency diseases Written by IMMUNE DEFICIENCY Sara LeBien FOUNDATION A note from the author The purpose of this book is to help young children who are immune deficient to better understand their immune system. What is a “B-cell,” a “T-cell,” an “immunoglobulin” or “IgG”? They hear doctors use these words, but what do they mean? With cheerful illustrations, Our Immune System explains how a normal immune system works and what treatments may be necessary when the system is deficient. In this second edition, a description of a new treatment has been included. I hope this book will enable these children and their families to explore together the immune system, and that it will help alleviate any confusion or fears they may have. Sara LeBien This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. SECOND EDITION COPYRIGHT 1990, 2007 IMMUNE DEFICIENCY FOUNDATION Copyright 2007 by Immune Deficiency Foundation, USA. Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. Our Immune System may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 40 West Chesapeake Avenue, Suite 308, Towson, MD 21204, USA; or by telephone at 1-800-296-4433.
    [Show full text]
  • Effector CD4 T-Cell Transition to Memory Requires Late Cognate Interactions That Induce Autocrine IL-2
    ARTICLE Received 3 Jun 2014 | Accepted 24 Sep 2014 | Published 5 Nov 2014 DOI: 10.1038/ncomms6377 Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2 K. Kai McKinstry1,*, Tara M. Strutt1,*, Bianca Bautista1, Wenliang Zhang1, Yi Kuang1, Andrea M. Cooper2 & Susan L. Swain1 It is unclear how CD4 T-cell memory formation is regulated following pathogen challenge, and when critical mechanisms act to determine effector T-cell fate. Here, we report that following influenza infection most effectors require signals from major histocompatibility complex class II molecules and CD70 during a late window well after initial priming to become memory. During this timeframe, effector cells must produce IL-2 or be exposed to high levels of paracrine or exogenously added IL-2 to survive an otherwise rapid default contraction phase. Late IL-2 promotes survival through acute downregulation of apoptotic pathways in effector T cells and by permanently upregulating their IL-7 receptor expression, enabling IL-7 to sustain them as memory T cells. This new paradigm defines a late checkpoint during the effector phase at which cognate interactions direct CD4 T-cell memory generation. 1 Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655, USA. 2 Trudeau Institute, 154 Algonquin Avenue, Saranac Lake, New York 12983, USA. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to K.K.M. (email: [email protected]). NATURE COMMUNICATIONS | 5:5377 | DOI: 10.1038/ncomms6377 | www.nature.com/naturecommunications 1 & 2014 Macmillan Publishers Limited.
    [Show full text]
  • Memory T Cells + Maintenance of CD8 the Dual Role of IL-2 in the Generation
    The Dual Role of IL-2 in the Generation and Maintenance of CD8 + Memory T Cells Zhenhua Dai, Bogumila T. Konieczny and Fadi G. Lakkis This information is current as J Immunol 2000; 165:3031-3036; ; of September 30, 2021. doi: 10.4049/jimmunol.165.6.3031 http://www.jimmunol.org/content/165/6/3031 Downloaded from References This article cites 31 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/165/6/3031.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 30, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Dual Role of IL-2 in the Generation and Maintenance of CD8؉ Memory T Cells1 Zhenhua Dai, Bogumila T. Konieczny, and Fadi G. Lakkis2 The mechanisms responsible for the generation and maintenance of T cell memory are unclear. In this study, we tested the role of IL-2 in allospecific CD8؉ T cell memory by analyzing the long-term survival, phenotype, and functional characteristics of IL-2-replete (IL-2؉/؉) and IL-2-deficient (IL-2؊/؊) CD8؉ TCR-transgenic lymphocytes in an adoptive transfer model.
    [Show full text]
  • Understanding the Immune System: How It Works
    Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute NIH Publication No. 03-5423 September 2003 www.niaid.nih.gov www.nci.nih.gov Contents 1 Introduction 2 Self and Nonself 3 The Structure of the Immune System 7 Immune Cells and Their Products 19 Mounting an Immune Response 24 Immunity: Natural and Acquired 28 Disorders of the Immune System 34 Immunology and Transplants 36 Immunity and Cancer 39 The Immune System and the Nervous System 40 Frontiers in Immunology 45 Summary 47 Glossary Introduction he immune system is a network of Tcells, tissues*, and organs that work together to defend the body against attacks by “foreign” invaders. These are primarily microbes (germs)—tiny, infection-causing Bacteria: organisms such as bacteria, viruses, streptococci parasites, and fungi. Because the human body provides an ideal environment for many microbes, they try to break in. It is the immune system’s job to keep them out or, failing that, to seek out and destroy them. Virus: When the immune system hits the wrong herpes virus target or is crippled, however, it can unleash a torrent of diseases, including allergy, arthritis, or AIDS. The immune system is amazingly complex. It can recognize and remember millions of Parasite: different enemies, and it can produce schistosome secretions and cells to match up with and wipe out each one of them.
    [Show full text]
  • A Novel BCMA/CD3 Bispecific T-Cell Engager for the Treatment
    OPEN Leukemia (2017) 31, 1743–1751 www.nature.com/leu ORIGINAL ARTICLE A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo S Hipp1, Y-T Tai2,3, D Blanset4, P Deegen5, J Wahl5, O Thomas5, B Rattel5, PJ Adam1, KC Anderson2,3 and M Friedrich5 B-cell maturation antigen (BCMA) is a highly plasma cell-selective protein that is expressed on malignant plasma cells of multiple myeloma (MM) patients and therefore is an ideal target for T-cell redirecting therapies. We developed a bispecific T-cell engager (BiTE) targeting BCMA and CD3ε (BI 836909) and studied its therapeutic impacts on MM. BI 836909 induced selective lysis of BCMA- positive MM cells, activation of T cells, release of cytokines and T-cell proliferation; whereas BCMA-negative cells were not affected. Activity of BI 836909 was not influenced by the presence of bone marrow stromal cells, soluble BCMA or a proliferation-inducing ligand (APRIL). In ex vivo assays, BI 836909 induced potent autologous MM cell lysis in both, newly diagnosed and relapsed/ refractory patient samples. In mouse xenograft studies, BI 836909 induced tumor cell depletion in a subcutaneous NCI-H929 xenograft model and prolonged survival in an orthotopic L-363 xenograft model. In a cynomolgus monkey study, administration of BI 836909 led to depletion of BCMA-positive plasma cells in the bone marrow. Taken together, these results show that BI 836909 is a highly potent and efficacious approach to selectively deplete BCMA-positive MM cells and represents a novel immunotherapeutic for the treatment of MM.
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]
  • Regulatory T Cell Research
    Regulatory T cell research Unique kits for cell isolation Harmonized cell culture and expansion tools Convenient functional assay tools Germany/Austria/ Benelux France Nordics and Baltics South Korea Switzerland Miltenyi Biotec B.V. Miltenyi Biotec SAS Miltenyi Biotec Norden AB Miltenyi Biotec Korea Co., Ltd Reliable flow cytometry analysis Miltenyi Biotec GmbH Schipholweg 68 H 10 rue Mercoeur Scheelevägen 17 Arigi Bldg. 8F Friedrich-Ebert-Straße 68 2316 XE Leiden 75011 Paris, France 223 70 Lund 562 Nonhyeon-ro 51429 Bergisch Gladbach The Netherlands Phone +33 1 56 98 16 16 Sweden Gangnam-gu Germany [email protected] Fax +33 1 56 98 16 17 [email protected] Seoul 06136, South Korea Phone +49 2204 8306-0 Customer service [email protected] Customer service Sweden Phone +82 2 555 1988 Fax +49 2204 85197 The Netherlands Phone 0200-111 800 Fax +82 2 555 8890 [email protected] Phone 0800 4020120 Italy Fax 046-280 72 99 [email protected] Fax 0800 4020100 Miltenyi Biotec S.r.l. Customer service Denmark USA/Canada Customer service Belgium Via Persicetana, 2/D Phone 80 20 30 10 Spain Miltenyi Biotec Inc. Phone 0800 94016 40012 Calderara di Reno (BO) Fax +46 46 280 72 99 Miltenyi Biotec S.L. 2303 Lindbergh Street Fax 0800 99626 Italy Customer service C/Luis Buñuel 2 Auburn, CA 95602, USA Customer service Luxembourg Phone +39 051 6 460 411 Norway, Finland, Iceland, Ciudad de la Imagen Phone 800 FOR MACS Phone 800 24971 Fax +39 051 6 460 499 and Baltic countries 28223 Pozuelo de Alarcón (Madrid) Phone +1 530 888 8871 Fax 800 24984 [email protected] Phone +46 46 280 72 80 Spain Fax +1 877 591 1060 Fax +46 46 280 72 99 Phone +34 91 512 12 90 [email protected] China Japan Fax +34 91 512 12 91 Miltenyi Biotec Technology & Miltenyi Biotec K.K.
    [Show full text]
  • The Anatomy of T-Cell Activation and Tolerance Anna Mondino*T, Alexander Khoruts*, and Marc K
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2245-2252, March 1996 Review The anatomy of T-cell activation and tolerance Anna Mondino*t, Alexander Khoruts*, and Marc K. Jenkins Department of Microbiology and the Center for Immunology, University of Minnesota Medical School, 420 Delaware Street S.E, Minneapolis, MN 55455 ABSTRACT The mammalian im- In recent years, it has become clear that TCR is specific for a self peptide-class I mune system must specifically recognize a full understanding of immune tolerance MHC complex) T cell that will exit the and eliminate foreign invaders but refrain cannot be achieved with reductionist in thymus and seed the secondary lymphoid from damaging the host. This task is vitro approaches that separate the individ- tissues (3, 4). In contrast, cortical CD4+ accomplished in part by the production of ual lymphocyte from its in vivo environ- CD8+ thymocytes that express TCRs that a large number of T lymphocytes, each ment. The in vivo immune response is a have no avidity for self peptide-MHC bearing a different antigen receptor to well-organized process that involves mul- complexes do not survive and die by an match the enormous variety of antigens tiple interactions of lymphocytes with each apoptotic mechanism. Cortical epithelial present in the microbial world. However, other, with bone-marrow-derived antigen- cells are essential for the process of pos- because antigen receptor diversity is gen- presenting cells (APCs), as well as with itive selection because they display the self erated by a random mechanism, the im- nonlymphoid cells and their products. The peptide-MHC complexes that are recog- mune system must tolerate the function of anatomic features that are designed to op- nized by CD4+ CD8+ thymocytes and also T lymphocytes that by chance express a timize immune tolerance toward innocuous provide essential differentiation factors self-reactive antigen receptor.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]
  • Maxpar Human Helper T-Cell
    PRD013-201318 Rev. 7 PRODUCT INFORMATION SHEET Maxpar Human Helper T Cell Phenotyping Panel Kit, 15 Marker—25 Tests Catalog: 201318 Storage: Package size: 25 tests • Antibodies, buffers, and water: 4 °C. Do not freeze. • Cell-ID Intercalator-Ir: –20 °C. Contents: Target Clone Metal Target Clone Metal • Maxpar® Cell Staining Buffer (500 mL) CD196/CCR6 G034E3 141Pr CD161 HP-3G10 159Tb • Maxpar Fix and Perm Buffer (25 mL) CD195/CCR5 NP-6G4 144Nd CD45RO UCHL1 165Ho • Maxpar Water (500 mL) CD8 RPA-T8 146Nd CD25 2A3 169Tm • Cell-IDTM Intercalator-Ir (125 µM; 25 µL) CD278/ICOS C398.4A 151Eu CD185/CXCR5 RF8B2 171Yb • Maxpar antibodies (see table for panel)* CD45RA HI100 153Eu CD4 SK3 174Yb CD3 UCHT1 154Sm CD279/PD-1 EH12.2H7 175Lu * The antibodies are provided in individual tubes, not a pre-mixed cocktail. CD183/CXCR3 G025H7 156Gd CD127 A019D5 176Yb CD194/CCR4 L291H4 158Gd Technical Information Description: The Maxpar Human Helper T Cell Phenotyping Panel Kit is for the identification and phenotyping of human CD4+ helper T cell subsets, including T helper 1 (TH1), TH2, TH17, TH22, T follicular helper (TFH), and T regulatory (TREG). Differentiation of CD4+ T cells into functionally distinct helper T subsets is essential for normal immunoregulation. These subsets are specified by extrinsic and intrinsic cues, and the resultant cell populations acquire stable phenotypes defined by the expression of signature cytokines, master regulator transcription factors, and characteristic cell surface phenotypes. Originally, CD4+ T cells were viewed as having only two major fates: 1) TH1 cells, which express T-bet and selectively produce interferon IFNγ and 2) TH2 cells, which express Gata3 and produce interleukin 4 (IL-4).
    [Show full text]
  • Effector Memory T Cells + Regulation of IL-17 in Human CCR6
    Regulation of IL-17 in Human CCR6+ Effector Memory T Cells Hong Liu and Christine Rohowsky-Kochan This information is current as J Immunol 2008; 180:7948-7957; ; of September 26, 2021. doi: 10.4049/jimmunol.180.12.7948 http://www.jimmunol.org/content/180/12/7948 Downloaded from References This article cites 25 articles, 9 of which you can access for free at: http://www.jimmunol.org/content/180/12/7948.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Regulation of IL-17 in Human CCR6؉ Effector Memory T Cells1 Hong Liu and Christine Rohowsky-Kochan2 IL-17–secreting T cells represent a distinct CD4؉ effector T cell lineage (Th17) that appears to be essential in the pathogenesis of numerous inflammatory and autoimmune diseases. Although extensively studied in the murine system, human Th17 cells have not been well characterized.
    [Show full text]
  • Peripheral T-Cell Lymphoma As an Elusive Cause of Progressive Eosinophilic Myocarditis Dylan Mart, MD; Jacob Luty, M.D.; Cristina Fuss, M.D.; Rebecca Harrison, M.D
    Diagnosis Under Pressure Peripheral T-Cell Lymphoma as an Elusive Cause of Progressive Eosinophilic Myocarditis Dylan Mart, MD; Jacob Luty, M.D.; Cristina Fuss, M.D.; Rebecca Harrison, M.D. Department of Medicine, Oregon Health and Science University Introduction Discussion Eosinophilic myocarditis (EM) is a rare cause of progressive PTCL describes a collection of disease entities with no defining myocardial dysfunction that has a broad array of inciting diseases clinical or phenotypic features, and constitute 4-10% of NHL 1 processes and many distinct complications. An elusive cause of EM is overall . There is an elevated incidence in Asian populations, as PTCL constitutes approximately 20% of all NHL2 presenting in that peripheral T-cell lymphoma (PTCL), a protean entity with varied group. presentations. We present a case of PTCL that defied diagnosis, Presenting symptoms are non-specific: Classic “B symptoms” only stressing the importance of a broad differential for causes of EM. present in 35% of cases3. Extra-nodal involvement is present in 49% of cases, solid organ involvement in 17%. Lab findings: - Elevated LDH ~50% of cases Case - Thrombocytopenia ~25% cases Previously healthy 49 year-old Cantonese woman originally presented for - Anemia ~25% of cases evaluation of chest pressure. Multiple previous presentations for - Eosinophilia – Variable progressive fatigue, workup at that time pertinent for: Histology: - Leukocytosis with prominent eosinophilia (69%) - Pleomorphic cell types, most commonly resembling T-cell - TTE with preserved EF, but demonstrating apical RV thrombus 6 phenotype - Cardiac MR demonstrating circumferential subendocardial late - Variable findings on immunohistochemistry, characteristically gadolinium enhancement lack typical “B” markers, and variably express mature T-cell - BMBx: basic autoimmune & infectious workup negative, markers (CD4,5,8, etc) - FNA of submandibular adenopathy technically suboptimal Adverse prognostic indicators3: Discharged on empiric trial of systemic steroids Microscopic findings in the liver.
    [Show full text]